A Phase I/II Study of the Tolerability, Safety and Pharmacokinetics of Oral Monepantel (MPL) in Individuals with Treatment-Refractory Solid Tumours.
Phase of Trial: Phase I/II
Latest Information Update: 16 Jul 2019
Price : $35 *
At a glance
- Drugs Monepantel (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- Sponsors PharmAust
- 23 Aug 2016 Status changed from recruiting to discontinued.
- 25 Jun 2014 New trial record